High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

By M. Zelefsky, Z. Fuks, Margie Hunt, Henry J. Lee, D. Lombardi, C. Ling, V. Reuter, E. Venkatraman, S. Leibel. Journal of Urology, 2001

726 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Radiation

View Paper: https://www.semanticscholar.org/paper/76a006b13f4a1dde41780391d0d06fc4b9d14c39

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. D. Kuban
2. S. Tucker
3. Lei Dong
4. G. Starkschall
5. E. Huang
6. M. R. Cheung
7. Andrew K. Lee
8. A. Pollack

Citations in the corpus

• Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer. (2017, neutral): “None 150 (25) 143 (24) 310 (51) 299 (50) 1 273 (45) 272 (46) 162 (27) 165 (28) 2 161 (27) 159 (27) 123 (20) 116 (19) 3 24 (3.”
• Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. (2008, result): “Although a previous retrospective analysis from Memorial Sloan-Kettering Cancer Center showed a dose benefit in the low-risk group (16), the Zietman et al.”
• Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. (2002, background): “Along with a number of convincing retrospective studies (2–6), there have been prospective sequential (6, 23, 24) trials and a randomized dose escalation trial (1), in addition to the MDACC trial reported here.”